|
|
|
| |
|
|
| |
The latest pulmonology news from News Medical |
|
|
|
 | | |  Missing gut bacteria in US babies triples allergy and eczema risk US infants lacking Bifidobacterium in their gut microbiome face significant changes in microbial composition, metabolic function, and immune-related health risks. This large, nationally representative study links early-life Bifidobacterium deficits to a three-fold increase in eczema, allergy, or asthma by age two. | | | | |  Improving fatty liver diagnosis through AI analysis of standard chest radiographs Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications, such as cirrhosis and liver cancer, making it crucial to detect early and initiate treatment. | |
|
|
| | | | |  As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked to replace experts he'd fired earlier met inside the Centers for Disease Control and Prevention's headquarters to plan a more skeptical vaccine future. | | | | |  Early postoperative levels of IL-6 and CRP are independently associated with infection risk after pulmonary cancer surgery. However, adding these biomarkers to standard clinical predictors provides only limited improvement in infection prediction. | | | | |  A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur 'catastrophic' health costs, new research published in The Lancet Global Health has found. | | | | |  Uncover the recent breakthroughs in asthma-targeted therapy. | | | | |  A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights." | | | | |  Breakthrough advancements in TSLP antibody tools are fueling biopharmaceutical development. | |
|
|
|
|
|
|
|
